This time we hear from RIKEN Hakubi Team Leader Masaya Hagiwara, who leads the Human Biomimetic System RIKEN Hakubi Research Team that joined the RIKEN BDR in April 2023, about his laboratory.
The Laboratory for Neuroepitranscriptomics was launched in April 2021 and is headed by Team Leader Dan Ohtan Wang. Originally from China, Dr. Wang first came to Japan as a high school student on a short-term exchange program, and then later returned to attend the Tokyo Institute of Technology for her undergraduate and …
Team Leader Fumiaki Obata joined RIKEN BDR in April 2021 from his former post at The University of Tokyo to lead the new Laboratory for Nutritional Biology. He first began working with fruit flies,
Launched in 2016, the RIKEN BDR-Otsuka Pharmaceutical Collaboration Center aspires to conceive novel and original results through collaborative research investigating disease mechanisms based on developmental, regenerative and systems biology approaches. In June 2020, the Neural Organogenesis Research Program headed by Hideya Sakaguchi was established to accelerate research specifically in areas of neurobiology and the understanding of neurodegenerative diseases.
In April 2020, the Laboratory for Dynamic Structure of Biomolecules, led by Team Leader Ichio Shimada, that is undertaking structural biology research using nuclear magnetic resonance (NMR) was launched at the Yokohama Campus.
The RIKEN Hakubi Fellows program offers outstanding and talented early-career scientists the opportunity to lead an independent team to pursue creative and ambitious research with the potential for high scientific and societal impact. This time, we introduce a team led by Hakubi Team leader Kyogo Kawaguchi…
At the RIKEN BDR-DAIKIN Collaboration Center, one of two collaboration centers established at BDR with a partnering company, BDR scientists researching human fatigue and Daikin Industries, Ltd., a global manufacturer of air conditioning systems, have teamed up to share and exchange their respective knowledge and technologies…
Two researchers with clinical knowledge and experience are leading respective teams under this program with the goal of advancing our understanding of diseases as well as developing applications for regenerative medicine.